Quantitative assessment of altered rectal mucosal permeability due to rectally applied nonoxynol-9, biopsy, and simulated intercourse

Journal of Infectious Diseases

Volumn 207, Issue 9, 2013, Pages 1389-1396

  Fuchs, Edward J ^a   Grohskopf, Lisa A ^b   Lee, Linda A ^a   Bakshi, Rahul P ^a   Hendrix, Craig W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

epithelial disruption; HIV rectal microbicide; mucosal permeability; Nonoxynol 9

Indexed keywords

NONOXINOL 9; NORMOSOL; PENTETATE TECHNETIUM TC 99M;

ARTICLE; COLON BIOPSY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG URINE LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUAL; MAXIMUM PLASMA CONCENTRATION; MEMBRANE PERMEABILITY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; RECTUM MUCOSA; RECTUM MUCOSA PERMEABILITY; SEXUAL INTERCOURSE; SIGMOIDOSCOPY; VIRUS TRANSMISSION;

BIOPSY; HUMANS; INTESTINAL MUCOSA; NONOXYNOL; PERMEABILITY; PLASMA; RADIOISOTOPES; RECTUM; SPERMATOCIDAL AGENTS; TECHNETIUM;

EID: 84875971126     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit030     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. Subpopulation estimates from the HIV incidence surveillance system-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:985-9.
2. Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Report no. 362. Hyattsville, MD: National Center for Health Statistics, 2005.
3. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360:971-7. (Pubitemid 35284107)
4. Watts DH, Rabe L, Krohn MA, Aura J, Hillier SL. The effects of three nonoxynol-9 preparations on vaginal flora and epithelium. J Infect Dis 1999; 180:426-37. (Pubitemid 30256325)
5. Rustomjee R, Abdool Karim Q, Abdool Karim SS, Laga M, Stein Z. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS 1999; 13:1511-5. (Pubitemid 29396683)
6. Gagné N, Cormier H, Omar RF, et al. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9. Sex Transm Dis 1999; 26:177-83. (Pubitemid 29122742)
7. Van Damme L, Niruthisard S, Atisook R, et al. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS 1998; 12:433-7. (Pubitemid 28077541)
8. Stafford MK, Ward H, Flanagan A, et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:327-31.
9. Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359:463-72.
10. Mesquita PM, Cheshenko N, Wilson SS, et al. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis 2009; 200:599-608.
11. Martin HL Jr, Stevens CE, Richardson BA, et al. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial. Sex Transm Dis 1997; 24: 279-83. (Pubitemid 27208979)
12. Phillips DM, Taylor CL, Zacharopoulos VR, Maguire RA. Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. Contraception 2000; 62:149-54.
13. Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA. Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception 2004; 70:107-10. (Pubitemid 38993485)
14. Tabet SR, Surawicz C, Horton S, et al. Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis 1999; 26:564-71. (Pubitemid 29523379)
15. Bjarnason I, Maxton D, Reynolds AP, Catt S, Peters TJ, Menzies IS. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterol 1994; 29:630-9. (Pubitemid 24203067)
16. Zamora SA, Hilsden RJ, Meddings JB, Butzner JD, Scott RB, Sutherland LR. Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol 1999; 13:31-6. (Pubitemid 29158479)
17. Hallemeesch MM, Lamers WH, Soeters PB, Deutz NE. Increased lactulose/rhamnose ratio during fluid load is caused by increased urinary lactulose excretion. Am J Physiol Gastrointest Liver Physiol 2000; 278: G83-8. (Pubitemid 30108071)
18. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Colch) 1986; 71:71-80. (Pubitemid 16045225)
19. Teahon K, Somasundaram S, Smith T, Menzies I, Bjarnason I. Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. Gut 1996; 38:864-9. (Pubitemid 26231771)
20. Jenkins RT, Ramage JK, Jones DB, Collins SM, Goodacre RL, Hunt RH. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med 1988; 11:151-5.
21. Obinna FC, Cook G, Beale T, et al. Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. AIDS 1995; 9:1009-16.
22. O'morain CA, Abelow AC, Chervu LR, Fleischner GM, Das KM. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108:430-5. (Pubitemid 17184419)
23. Rask-Madsen J, Schwartz M. Absorption of 51Cr-EDTA in ulcerative colitis following rectal instillation. Scand J Gastroenterol 1970; 5:361-8.
24. Jorgensen VL, Nielsen SL, Espersen K, Perner A. Increased colorectal permeability in patients with severe sepsis and septic shock. Intensive Care Med 2006; 32:1790-6. (Pubitemid 44607367)
25. Feil W, Lacy ER, Wong YM, Burger D, Wenzl E, Starlinger M, Schiessel R. Rapid epithelial restitution of human and rabbit colonic mucosa. Gastroenterology 1989; 97:685-701. (Pubitemid 19205142)
26. Hylton J, Fuchs EJ, Hendrix CW. An assessment of sexual practices affecting the feasibility of microbicide development among MSM. Presented at: Microbicides 2004, London, United Kingdom, 28-31 March 2004. Poster# 02667.
27. Division of AIDS table for grading the severity of adult and pediatric adverse events; Version 1.0. December 2004. Clarification August 2009. http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table-for-Grading- Severity-of-Adult-Pediatric-Adverse-Events.doc. Accessed 5 November 2012.
28. Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, Wahl RL, Hendrix CW. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis 2007; 195:703-10.
29. Wilson SS, Cheshenko N, Fakioglu E, Mesquita PM, Keller MJ, Herold BC. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety. Antivir Ther 2009; 14:1113-24.